App-Quantinova.ai

Association of intermittent or continuous androgen deprivation therapy with cardiovascular disease and endocrine/metabolic disorders in patients with nonmetastatic prostate cancer.

Alicia K. Morgans - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Androgen Tear

Association between hypertensive disorders of pregnancy and new cardiovascular diseases within 24 months postpartum

Christina M. Ackerman-Banks - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Severe maternal morbidity among people with cardiac disease: getting to the heart of the problem

Kelly F. Darmawan - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Validation of maternal co-morbidity diagnoses using differential data extraction strategies across a large health system

Adina R. Kern-Goldberger - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Substance Abuse

Heart muscle disease

N/A

Association between prenatal depression and new cardiovascular disease within 24 months’ postpartum

Christina M. Ackerman-Banks - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Prenatal exome sequencing versus targeted gene panel for evaluation of fetal congenital heart defects

Matthew Shear - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

A severe fetal arrhythmia with a good outcome: case report and literature review

T. Zhou - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Heart muscle disease

N/A

Impact of increased surveillance on perinatal management and outcome of fetuses with congenital heart disease

T. Trakulmungkichkarn - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Heart muscle disease

N/A

Management of Noonan syndrome in pregnancy

K. Singhal - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Prenatal feature prenatal findings of a case of Noonan syndrome and Noonan syndrome-like disorders

A. Kondo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Prenatal diagnosis of a case of Noonan syndrome with RAF1 gene mutation using clinical-exome sequencing

S.T. Vo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Prenatal diagnosis of fetal non-compaction cardiomyopathy with de novo CALM 2 mutation: first description

W. Zhang - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Penicillin

Hypertrophic cardiomyopathy and hydrops fetalis likely associated with homozygous pathogenic variant in the ALPK3 gene

A. Balachandran - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention of the Left Anterior Descending Artery

Michael Megaly - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Invasive Assessment of Coronary Microvascular Dysfunction in Patients With Arrhythmia-Induced Cardiomyopathy

Alice Benedetti - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure With Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

Tamaz Shaburishvili - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure: EASE HF

Gil Vardi - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Right Ventricular Failure in Patients Presenting With Takotsubo Cardiomyopathy

Aaqib Malik - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Safety of Right and Left Ventricular Endomyocardial Biopsy in Heart Transplant and Cardiomyopathy Patients

Konstantinos Bermpeis - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

In-Hospital and 1-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Supplemental Home Oxygen Use

Nicole Hoover - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Filters

3340 Abstracts